Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hamid Emamekhoo

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
JCO Clinical Cancer Informatics|January 13, 2023
Patterns of Health Portal Use by Regular Portal Users Among Patients With Cancer: Results From the UWCCC Survivorship ProgramHamid Emamekhoo, Thevaa Chandereng, Mary E Sesto, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 29, 2026
HSR26-206: The Future of Oncology Research: Replacing Case Report Forms With mCODE-Aligned Electronic Health Record Data for Clinical Trial Data Curation (Alliance)Amye J Tevaarwerk, Nancy Campbell, Hamid Emamekhoo, et al.
Cancer Medicine|August 28, 2021
Patterns and predictors of cancer-specific patient health portal usage among patients with cancer: results from the UWCCC Survivorship ProgramRebecca P Luoh, Amye J Tevaarwerk, Thevaa Chandereng, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
HSR26-206: The Future of Oncology Research: Replacing Case Report Forms With mCODE-Aligned Electronic Health Record Data for Clinical Trial Data Curation (Alliance)Amye J Tevaarwerk, Nancy Campbell, Hamid Emamekhoo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 27, 2021
Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot studyNežka Hribernik, Daniel T Huff, Andrej Studen, et al.
JCO Clinical Cancer Informatics|July 8, 2022
Supporting Structured Data Capture for Patients With Cancer: An Initiative of the University of Wisconsin Carbone Cancer Center Survivorship Program to Improve Capture of Malignant Diagnosis and Cancer Staging DataHamid Emamekhoo, Cibele B Carroll, Chelsea Stietz, et al.
Journal for Immunotherapy of Cancer|December 15, 2023
Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancerDouglas G McNeel, Hamid Emamekhoo, Jens C Eickhoff, et al.
Oncotarget|April 24, 2018
<i>ATM/RB1</i> mutations predict shorter overall survival in urothelial cancerMing Yin, Petros Grivas, Hamid Emamekhoo, et al.
The Prostate|June 9, 2018
Treatment selection for men with metastatic prostate cancer who progress on upfront chemo-hormonal therapyPedro Barata, Hamid Emamekhoo, Prateek Mendiratta, et al.
Oligonucleotides|December 10, 2009
Sequence-specific correction of genomic hypoxanthine-guanine phosphoribosyl transferase mutations in lymphoblasts by small fragment homologous replacementBabak Bedayat, Alireza Abdolmohamadi, Lin Ye, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
JCO Clinical Cancer Informatics|January 13, 2023
Patterns of Health Portal Use by Regular Portal Users Among Patients With Cancer: Results From the UWCCC Survivorship ProgramHamid Emamekhoo, Thevaa Chandereng, Mary E Sesto, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 29, 2026
HSR26-206: The Future of Oncology Research: Replacing Case Report Forms With mCODE-Aligned Electronic Health Record Data for Clinical Trial Data Curation (Alliance)Amye J Tevaarwerk, Nancy Campbell, Hamid Emamekhoo, et al.
Cancer Medicine|August 28, 2021
Patterns and predictors of cancer-specific patient health portal usage among patients with cancer: results from the UWCCC Survivorship ProgramRebecca P Luoh, Amye J Tevaarwerk, Thevaa Chandereng, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
HSR26-206: The Future of Oncology Research: Replacing Case Report Forms With mCODE-Aligned Electronic Health Record Data for Clinical Trial Data Curation (Alliance)Amye J Tevaarwerk, Nancy Campbell, Hamid Emamekhoo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 27, 2021
Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot studyNežka Hribernik, Daniel T Huff, Andrej Studen, et al.
JCO Clinical Cancer Informatics|July 8, 2022
Supporting Structured Data Capture for Patients With Cancer: An Initiative of the University of Wisconsin Carbone Cancer Center Survivorship Program to Improve Capture of Malignant Diagnosis and Cancer Staging DataHamid Emamekhoo, Cibele B Carroll, Chelsea Stietz, et al.
Journal for Immunotherapy of Cancer|December 15, 2023
Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancerDouglas G McNeel, Hamid Emamekhoo, Jens C Eickhoff, et al.
Oncotarget|April 24, 2018
<i>ATM/RB1</i> mutations predict shorter overall survival in urothelial cancerMing Yin, Petros Grivas, Hamid Emamekhoo, et al.
The Prostate|June 9, 2018
Treatment selection for men with metastatic prostate cancer who progress on upfront chemo-hormonal therapyPedro Barata, Hamid Emamekhoo, Prateek Mendiratta, et al.
Oligonucleotides|December 10, 2009
Sequence-specific correction of genomic hypoxanthine-guanine phosphoribosyl transferase mutations in lymphoblasts by small fragment homologous replacementBabak Bedayat, Alireza Abdolmohamadi, Lin Ye, et al.
Pageof 7